.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Boehringer Ingelheim
UBS
Julphar
US Army
Baxter
Teva
Moodys
McKesson

Generated: July 22, 2017

DrugPatentWatch Database Preview

SODIUM IODIDE I 131 Drug Profile

« Back to Dashboard

What is the patent landscape for Sodium Iodide I 131, and when can generic versions of Sodium Iodide I 131 launch?

Sodium Iodide I 131 is a drug marketed by Jubilant Draximage, Mallinkrodt Nuclear, and CIS. and is included in five NDAs.

The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand three hundred and ninety-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.

Summary for Tradename: SODIUM IODIDE I 131

Patents:0
Applicants:3
NDAs:5
Suppliers / Packagers: see list2
Clinical Trials: see list2,541
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM IODIDE I 131 at DailyMed

Pharmacology for Tradename: SODIUM IODIDE I 131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Draximage
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL021305-006May 19, 2005RXYesNo► Subscribe► Subscribe
Cis
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL017316-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Cis
SODIUM IODIDE I 131
sodium iodide i-131
SOLUTION;ORAL017315-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL016517-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Jubilant Draximage
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL021305-004Nov 18, 2004DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Dow
AstraZeneca
Julphar
Cipla
Citi
McKesson
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot